OrthoPediatrics/KIDS

$31.09

-1.48%
-
1D1W1MYTD1YMAX

About OrthoPediatrics

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.

Ticker

KIDS

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Mark Throdahl

Employees

247

Headquarters

Warsaw, United States

OrthoPediatrics Metrics

BasicAdvanced
$750.69M
Market cap
-
P/E ratio
-$0.93
EPS
1.17
Beta
-
Dividend rate
$750.69M
1.16672
$53.50
$23.10
178.12K
5.436
2.896
2.628
2.668
-4.84%
-5.55%
-5.28%
5.047
1.957
3.596
21.62%
-19,096.71%
27.91%

What the Analysts think about OrthoPediatrics

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 6 analysts.
27.05% upside
High $50.00
Low $32.00
$31.09
Current price
$39.50
Average price target

OrthoPediatrics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-17.55% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$37.6M
-5.76%
Net income
$-6.6M
46.67%
Profit margin
-17.55%
55.72%

OrthoPediatrics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 3.41%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.30
-$0.13
-$0.20
-$0.29
-
Expected
-$0.36
-$0.22
-$0.23
-$0.28
-$0.40
Surprise
-17.78%
-39.89%
-10.28%
3.41%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for OrthoPediatrics stock?

OrthoPediatrics (KIDS) has a market cap of $750.69M as of April 13, 2024.

What is the P/E ratio for OrthoPediatrics stock?

The price to earnings (P/E) ratio for OrthoPediatrics (KIDS) stock is 0 as of April 13, 2024.

Does OrthoPediatrics stock pay dividends?

No, OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders as of April 13, 2024.

When is the next OrthoPediatrics dividend payment date?

OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders.

What is the beta indicator for OrthoPediatrics?

OrthoPediatrics (KIDS) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the OrthoPediatrics stock price target?

The target price for OrthoPediatrics (KIDS) stock is $39.5, which is 27.05% above the current price of $31.09. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell OrthoPediatrics stock

Buy or sell OrthoPediatrics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing